First Trust Direct Indexing’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,070
Closed -$1.22M 956
2024
Q3
$1.22M Buy
9,070
+78
+0.9% +$10.4K 0.07% 301
2024
Q2
$1.22M Buy
8,992
+1,080
+14% +$147K 0.08% 272
2024
Q1
$1.02M Buy
7,912
+469
+6% +$56.7K 0.08% 291
2023
Q4
$851K Buy
7,443
+2,941
+65% +$294K 0.08% 304
2023
Q3
$410K Sell
4,502
-506
-10% -$52.2K 0.05% 445
2023
Q2
$564K Buy
5,008
+2,059
+70% +$218K 0.06% 375
2023
Q1
$309K Buy
2,949
+94
+3% +$9.82K 0.04% 533
2022
Q4
$316K Sell
2,855
-287
-9% -$30.1K 0.04% 495
2022
Q3
$274K Sell
3,142
-491
-14% -$44.6K 0.04% 493
2022
Q2
$284K Sell
3,633
-168
-4% -$13.9K 0.04% 486
2022
Q1
$324K Buy
3,801
+518
+16% +$49.6K 0.04% 481
2021
Q4
$394K Buy
3,283
+12
+0.4% +$1.49K 0.05% 418
2021
Q3
$405K Buy
+3,271
New +$421K 0.06% 397

Other funds holding XYL

First Trust Direct Indexing's XYL Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Xylem (XYL) in Q4 2024, closing a stake of 9,070 shares — an estimated $1.22M sold.

First Trust Direct Indexing first reported a position in XYL in Q3 2021 and held it in 13 quarters. The position peaked at $1.22M in Q3 2024. 1,001 funds tracked by Wall St. Rank hold XYL as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Xylem position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 9,070 Xylem shares in Q4 2024, an estimated $1.22M.
  • First Trust Direct Indexing first reported a position in Xylem in Q3 2021 and held it in 13 quarters.
  • First Trust Direct Indexing's Xylem position peaked at $1.22M in Q3 2024.
  • 1,001 funds tracked by Wall St. Rank held Xylem as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.